| Authors: |
Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Appierto V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Reduzzi C; Liquid Biopsy Platform, Division of Hematology/Oncology, Weill Cornell Medicine, New York, New York, USA., De Cecco L; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Valenza C; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Gerratana L; Department of Medicine, University of Udine, Udine, Italy.; Department of Medical Oncology, CRO Aviano, National Cancer Institute IRCCS, Aviano, Italy., Agostinetto E; Service de Oncologie, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Translational Oncology Group, Department of Medicine, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera, Centro de Estudios Universitarios, Alfara del Patriarca, Spain.; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain., Ignatiadis M; Service de Oncologie, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium., Cortes J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; International Breast Cancer Center-Pangaea Oncology, Quirón Group, Barcelona, Spain.; IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Cristofanilli M; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, New York, USA., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pruneri G; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. |
